FUSIONNER™ TECHNOLOGY
Fusionner™ technology uses a self-emulsifying delivery system (SEDDS), designed to improve the solubility and absorption of cannabinoids, thereby increasing bioavailability and contributing to greater consistency and predictability of clinical effects.
Introduction
The therapeutic efficacy of cannabinoids is often limited by their low water solubility and bioavailability. water and bioavailability. Fusionner seeks to overcome these challenges by using a SEDDS.
SEDDS formulation
The SEDDS formulation consists of oil, surfactants and co-surfactants that self-emulsify. This technology allows cannabinoids to be dispersed into tiny particles, improving their solubility and absorption.
Clinical Benefits
Increased absorption: SEDDS technology facilitates the absorption of cannabinoids, enhancing the therapeutic response.
Reduced side effects: optimizes delivery, making treatment more comfortable for patients.
Greater accessibility: More effective and affordable for a wide range of patients.
Components
- Oil: lipophilic carrier for cannabinoids.
- Surfactants: facilitates emulsification, increasing solubility.
- Co-surfactants: help stabilize the emulsion.
Clinical Application
Fusionnercan be incorporated into various therapeutic approaches, including the treatment of chronic pain, epilepsy, anxiety, and other conditions.